Dario Giugliano

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 186 publications

Glucagon-like peptide-1 receptor agonists and major limb events in adults with type 2 diabetes and peripheral artery disease: a systematic review and meta-analysis of RCTs and cohort studies.

Glucagon-like peptide-1 receptor agonists and major limb events in adults with type 2 diabetes and peripheral artery disease: a systematic review and meta-analysis of RCTs and cohort studies.

Journal: Cardiovascular diabetology

Published: April 24, 2026

GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies.

GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies.

Journal: Diabetes, obesity & metabolism

Published: October 30, 2025

Glucagon-like peptide 1 receptor agonist for peripheral artery disease: Is it time to proceed?

Glucagon-like peptide 1 receptor agonist for peripheral artery disease: Is it time to proceed?

Journal: Diabetes, obesity & metabolism

Published: October 15, 2025

The therapeutic efficacy of continuous glucose monitoring in diabetes: an updated meta-analysis with meta-regression.

The therapeutic efficacy of continuous glucose monitoring in diabetes: an updated meta-analysis with meta-regression.

Journal: Endocrine

Published: June 25, 2025

BEYOND 4 years: simplification of complex insulin regimens with a fixed-ratio combination of basal insulin plus a GLP-1 receptor agonist or basal insulin plus an SGLT-2 inhibitor.

BEYOND 4 years: simplification of complex insulin regimens with a fixed-ratio combination of basal insulin plus a GLP-1 receptor agonist or basal insulin plus an SGLT-2 inhibitor.

Journal: Diabetologia

Published: June 19, 2025

Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts.

Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts.

Journal: Diabetes, obesity & metabolism

Published: May 10, 2025

Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index.

Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index.

Journal: Diabetes/metabolism research and reviews

Published: April 28, 2025

Fixed-ratio combination of GLP-1 receptor agonist and basal insulin: simplifying type 2 diabetes treatment.

Fixed-ratio combination of GLP-1 receptor agonist and basal insulin: simplifying type 2 diabetes treatment.

Journal: Endocrine

Published: March 25, 2025

Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial.

Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial.

Journal: Diabetes, obesity & metabolism

Published: March 18, 2025

Effect of SGLT-2 Inhibitors Versus DPP-4 Inhibitors on Peripheral Artery Disease Risk Among People With Type 2 Diabetes: A 48-Month Prospective Study.

Effect of SGLT-2 Inhibitors Versus DPP-4 Inhibitors on Peripheral Artery Disease Risk Among People With Type 2 Diabetes: A 48-Month Prospective Study.

Journal: Diabetes, obesity & metabolism

Published: January 07, 2025

Semaglutide cuts kidney risk in obesity.

Semaglutide cuts kidney risk in obesity.

Journal: Journal of endocrinological investigation

Published: September 26, 2024

Management of acute kidney disease in type 2 diabetes: the potential role of GLP-1 RAs and SGLT2-Is.

Management of acute kidney disease in type 2 diabetes: the potential role of GLP-1 RAs and SGLT2-Is.

Journal: Journal of nephrology

Published: August 05, 2024

Showing 1-12 of 186

Last Updated: 09/26/2026